APA (7th ed.) Citation

Tisseur, L., Cojean, S., Gassama, K., Logé, C., Pagniez, F., Cavé, C., . . . Marchand, P. (2025). Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition. ChemMedChem.

Chicago Style (17th ed.) Citation

Tisseur, Lhana, et al. Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in Vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition. ChemMedChem, 2025.

MLA (9th ed.) Citation

Tisseur, Lhana, et al. Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in Vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition. ChemMedChem, 2025.